- Research article
- Open Access
DNA methylation status of nuclear-encoded mitochondrial genes underlies the tissue-dependent mitochondrial functions
© Takasugi et al; licensee BioMed Central Ltd. 2010
- Received: 27 February 2010
- Accepted: 19 August 2010
- Published: 19 August 2010
Mitochondria are semi-autonomous, semi-self-replicating organelles harboring their own DNA (mitochondrial DNA, mtDNA), and their dysregulation is involved in the development of various diseases. While mtDNA does not generally undergo epigenetic modifications, almost all mitochondrial proteins are encoded by nuclear DNA. However, the epigenetic regulation of nuclear-encoded mitochondrial genes (nuclear mt genes) has not been comprehensively analyzed.
We analyzed the DNA methylation status of 899 nuclear mt genes in the liver, brain, and heart tissues of mouse, and identified 636 nuclear mt genes carrying tissue-dependent and differentially methylated regions (T-DMRs). These nuclar mt genes are involved in various mitochondrial functions and they also include genes related to human diseases. T-DMRs regulate the expression of nuclear mt genes. Nuclear mt genes with tissue-specific hypomethylated T-DMRs were characterized by enrichment of the target genes of specific transcription factors such as FOXA2 in the liver, and CEBPA and STAT1 in the brain.
A substantial proportion of nuclear mt genes contained T-DMRs, and the DNA methylation status of numerous T-DMRs should underlie tissue-dependent mitochondrial functions.
- Methylation Status
- Specific Transcription Factor
- Sodium Metabisulfite
- GeneChip Mouse
- Combine Bisulfite Restriction Analysis
Mitochondrial dysfunction is a common cause of human diseases [1, 2], and thus understanding the regulation of mitochondrial functions is critical. Mitochondria do not contain histones , and almost all mtDNA is unmethylated [4, 5], indicating that mtDNA is not epigenetically regulated. However, while mammalian mitochondria are estimated to consist of more than 1,500 proteins, only 13 proteins are encoded by mtDNA.
Methylation of nuclear DNA is a major component of epigenetic system in mammalian cells, and is involved in silencing of gene transcription and maintaining genomic stability [6, 7]. Hypomethylation of regulatory regions is required to allow expression of genes [8, 9]. Microarray-based DNA methylation analysis revealed the existence of thousands of tissue-dependent and differentially methylated regions (T-DMRs) in the mouse and human genomes [10, 11]. While the T-DMRs of some genes, such as Oct-4 and Nanog, are hypomethylated only in a few cells [12, 13], the methylation status of most T-DMRs is not specific, but common to certain cells or tissues [11, 14]. Tissue-dependent methylation status of T-DMRs, including tissue-specific methylation status of T-DMRs, forms a distinctive DNA methylation profile for each cell type [8, 11, 15].
A nuclear mt gene, Ant4, which encodes mitochondrial outer membrane protein, contains T-DMRs which is specifically hypomethylated in the testis [16, 17]. Also, few dozens of nuclear mt genes in mice are hypomethylated in the liver relative to the cerebrum . However, the presence of T-DMRs in nuclear mt genes has not been comprehensively analyzed; this is necessary for understanding the regulation of mitochondrial functions. In this study, we analyzed the DNA methylation of 899 nuclear mt genes in the liver, brain, and heart tissues of mouse; these tissues consume large amounts of energy and are highly susceptible to mitochondrial dysfunctions. Our results indicated that at least 636 nuclear mt genes, which account for 71% of the total investigated nuclear mt genes, contain T-DMRs in their transcription start site (TSS) flanking regions (-7~+3 kb of TSSs), and that the differential methylation status of these T-DMRs is associated with tissue-dependent mitochondrial functions.
Identification of T-DMRs in the TSS flanking regions of nuclear mt genes in the liver, brain, and heart tissues
Nuclear mt genes with hypo T-DMRs
Various mitochondrial functions
Abat, Acsl5, Oat, etc
Dmgdh, Mthfd1, Star, etc
Cpt1b, Efta, Pdk4, etc
Atp5o, Ndufb2, etc
Atp5l, Cox6, Ndufs8, etc
Atp5l, Ndufs4, Sdhc, etc
Gsr, Hagh, Mgst1, Tst
Tissue-specific mitochondrial functions
Regulation of mitochondrial morphology
Regulation of mtDNA
Translation of mtDNA-encoded proteins
Human homologs of mouse nuclear mt genes possessing T-DMRs are related to various human diseases. For example, mutations of Lrpprc, Ndufs4, and Ndufs8, the genes with liver-, brain-, and heart-hypo T-DMRs, respectively, are associated with Leigh's disease [21–23]. In addition to mutations, overexpression of some nuclear mt genes with liver-hypo T-DMRs in non-liver tissues are involved in the human diseases. For example, overexpression of Acsl5 and Tgm2 are found in the human glioma and brain of Huntington's disease and are suggested to be involved in pathogenesis [24, 25].
Correlation between the DNA methylation status of T-DMRs and nuclear mt gene expression
Concentration of liver-hypo T-DMRs in the downstream regions of nuclear mt genes
Overrepresented transcriptional regulatory motifs in nuclear mt genes with liver- and brain-hypo T-DMRs
We next investigated whether T-DMRs of nuclear mt genes are associated with any transcriptional regulatory motifs. FOXA2 is a transcription factor that activates the genes involved in mitochondrial β-oxidation and the regulation of lipid metabolism, ketogenesis, and insulin sensitivity in the mouse liver [28, 29]. We analyzed the enrichment of genes containing FOXA2-binding sites within an extended gene region (encompassing 10 kb upstream of TSS and 1 kb downstream of the 3' UTR) using known genome-wide FOXA2-binding sites in the mouse liver obtained by ChIP-sequencing . We found that the targets of FOXA2 were enriched 1.6-fold in nuclear mt genes with liver-hypo T-DMRs relative to all nuclear mt genes (P < 5 × 10-5, Fisher's exact test). Sixty-four out of 123 nuclear mt genes with liver-hypo T-DMRs were the targets of FOXA2 (Additional file 6). This is contrast to the previous report, which indicated enrichment of target genes of HNF1 and/or HNF4 in hypomethylated genes in the mouse liver .
Transcription factors whose binding-sites were enriched in analyzed sequences
Number of targets
3.1 × 10-2
3.6 × 10-2
2.3 × 10-2
2.5 × 10-2
At least 71% of investigated nuclear mt genes contains T-DMRs, and the methylation status of T-DMRs correlated with tissue-dependent expression of dozens of nuclear mt genes. Considering that there are at least 200 different cell types in the mammalian body, the total number of nuclear mt genes with T-DMRs will be higher. The differences in protein composition of mitochondria are reported to reflect tissue-dependent nuclear mt gene expression . Our data suggest that DNA methylation status of nuclear mt genes underlies tissue-dependent mitochondrial functions.
C57BL/6N male mice were obtained from Charles River Japan. Mice were euthanized at 12-13 week old, and tissues were collected and frozen at -80°C until use. All experiments using mice were carried out according to the institutional guidelines for the care and use of laboratory animals (Graduate School of Agriculture and Life Sciences, The University of Tokyo).
Genomic DNA extraction
Genomic DNA was extracted as described previously . Briefly, tissue samples were homogenized, and incubated with lysis solution (10 mM Tris-HCl at pH 8.0, 5 mM EDTA, 200 mM NaCl, 0.2% SDS, and 200 μg/mL proteinase K) at 55°C for 30 min, and were extracted with a phenol/chloroform/isoamylalcohol (PCI) mixture (50 : 49 : 1), incubated with RNase for 30 min, and re-extracted with PCI. DNA was precipitated with ethanol and dissolved in Tris-EDTA (TE) buffer (pH 8.0).
We used T-DMR profiling with restriction-tag mediated amplification (D-REAM) analysis  to obtain tissue-dependent and differentially methylated HpyCH4IV sites within the TSS flanking regions of RefSeq genes. For D-REAM analysis, HpyCH4IV-digested genomic DNA was extracted with PCI, re-extracted with chloroform, precipitated with ethanol and dissolved in TE (pH 8.0). Using purified DNA (250 ng), following procedure of D-REAM analysis was performed as described previously . Briefly, genomic DNA was digested by the methyl-sensitive enzyme HpyCH4IV (New England Biolabs), followed by ligation-mediated PCR, and subsequent hybridization of DNA to a GeneChip Mouse Promoter 1.0R Array (Affymetrix). Comparison of the resulting signals from digested HpyCH4IV sites between different tissue samples indicates the differential methylation level at a given site.
D-REAM analysis was performed twice for each of the biological duplicates of heart, and once for the liver and brain in this study. For the liver and brain, we added single D-REAM data set from our previous study using tissues from different individual . Correlation coefficients of microarray probe intensities between biological duplicates were greater than 0.93. D-REAM data obtained in this study has been deposited in the ArrayExpress database (accession number A-MEXP-791).
Combined bisulfite restriction analysis (COBRA)
Genomic DNA was digested with HindIII (Takara). Digested DNA (5 μg) was denatured with 0.3 M NaOH. Sodium metabisulfite (pH 5.0) and hydroquinone were added to a final concentration of 2.0 M and 0.5 mM, respectively. The reaction mixture was incubated under following conditions: 15 cycles of 95°C for 30 s and 50°C for 15 min. Next, 1.77 volume of QG buffer was added to the reaction mixture, and DNA was purified using a Quiagen gel extraction kit (Qiagen), and eluted with 100 μl of elution buffer (EB). DNA was treated with 0.3 M NaOH at 37°C for 15 min, precipitated using 6 M ammonium acetate (pH 7.0) and ethanol, and dissolved in 200 μl TE (pH 8.0). For each bisulfite PCR, 2 μl of DNA solution was used as the template, and BIOTAQ HS DNA polymerase (Bioline) was used for amplification. PCR was performed under the following conditions: denaturation at 95°C for 10 min followed by 43 cycles, each cycle comprising 95°C for 30 sec, 60°C for 45 sec, 72°C for 30 sec, followed by 10 min at 72°C. All primers used in this experiment are listed in Additional file 2. The PCR product was digested with HpyCH4IV. Restriction-enzyme-treated DNA was desalted using gel filtration through Sephadex G-50, and was analyzed using the MultiNA microchip electrophoresis system (Shimadzu). The methylation level was calculated as the ratio of the amounts of cut fragments to those of the total of cut and uncut fragments obtained from the electropherograms.
RNA extraction, reverse transcription, and real-time PCR
Total RNA was prepared using TRIzol reagent (Invitrogen). Before synthesis of first-strand cDNA, the RNA preparation was treated with RNase-free DNase I (Invitrogen) to eliminate any residual genomic DNA. The total RNA was then converted into first-strand cDNA using random hexamers and Superscript III First-Strand Synthesis System for RT-PCR (Invitrogen). The obtained cDNA were amplified and quantified in triplicates by using the Quantitect SYBR Green PCR Kit (Qiagen) with ABI 7500 Real Time PCR system (Applied Biosystems). PCR was performed under the following conditions: Incubation at 95°C for 10 min followed by 40 cycles of PCR, each cycle comprising 95°C for 15 sec and 60°C for 1 min. All primers used in this experiment are listed in Additional file 8. Standard curves were obtained with serial dilutions of a pool of cDNA samples derived from each tissue.
MAT  was used to analyze the tiling array data (.CEL files) and identify the hypomethylated regions based on tiling probe signals, probe sequences, and copy numbers. Original tiling probes were remapped to the mouse genome assembly version mm9 (July 2007 build) provided by UCSC genome database. For the quality control of D-REAM analysis, we monitored the selective amplification of HpyCH4IV-digested fragments for the tilling array data of each sample (Additional file 9).
For expression analysis, data from the GeneChip Mouse Genome 430 2.0 Array of liver, heart, and cerebral cortex tissues of C57BL/6N male mice (8-10 week old; n = 2 for each tissue) were downloaded from Gene Expression Omnibus (accession no. GSE10246). The array image data (.CEL files) was processed by the factor analysis for robust microarray summarization algorithm (FARMS) with quantile normalization .
Enrichment analysis of specific transcription factor targets was performed using oPOSSUM program . This program analyzed the genes using one-to-one human-mouse orthologs and detected promoter motifs in the conserved regions. The top 10% of the non-coding conserved regions with an absolute minimum percent identity of 70% in each 5 kb region upstream and downstream of the TSSs were analyzed for vertebrate promoter motifs with a matrix match threshold of 75%.
This research was funded by grants from the National Institute of Biomedical Innovation (NIBIO); Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The authors declare no conflicts of interest. We would like to thank Dr. Shinya Sato and Mr. Hiroki Muramoto for their helpful suggestions regarding bioinformatic analysis.
- Enns GM: The contribution of mitochondria to common disorders. Mol. Genet. Metab. 2003, 80: 11-26. 10.1016/j.ymgme.2003.08.009.PubMedView ArticleGoogle Scholar
- Schapira AHV: Mitochondrial disease. Lancet. 2006, 368: 70-82. 10.1016/S0140-6736(06)68970-8.PubMedView ArticleGoogle Scholar
- Caron F, Jacq C, Rouvière-Yaniv J: Characterization of a histone-like protein extracted from yeast mitochondria. Proc. Natl. Acad. Sci. USA. 1979, 76: 4265-4269. 10.1073/pnas.76.9.4265.PubMed CentralPubMedView ArticleGoogle Scholar
- Dawid IB: 5-methylcytidylic acid: absence from mitochondrial DNA of frogs and HeLa cells. Science. 1974, 184: 80-81. 10.1126/science.184.4132.80.PubMedView ArticleGoogle Scholar
- Groot GS, Kroon AM: Mitochondrial DNA from various organisms does not contain internally methylated cytosine in -CCGG- sequences. Biochim. Biophys. Acta. 1979, 564: 355-357.PubMedView ArticleGoogle Scholar
- Chen T, Li E: Structure and function of eukaryotic DNA methyltransferases. Curr. Top. Dev. Biol. 2004, 60: 55-89. full_text.PubMedView ArticleGoogle Scholar
- Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31: 89-97. 10.1016/j.tibs.2005.12.008.PubMedView ArticleGoogle Scholar
- Shiota K: DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res. 2004, 105: 325-334. 10.1159/000078205.PubMedView ArticleGoogle Scholar
- Lieb JD, Beck S, Bulyk ML, Farnham P, Hattori N, Henikoff S, Liu XS, Okumura K, Shiota K, Ushijima T, Greally JM: Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenet Genome Res. 2006, 114: 1-15. 10.1159/000091922.PubMed CentralPubMedView ArticleGoogle Scholar
- Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Gräf S, Tomazou EM, Bäckdahl L, Johnson N, Herberth M, Howe KL, Jackson DK, Miretti MM, Fiegler H, Marioni JC, Birney E, Hubbard TJP, Carter NP, Tavaré S, Beck S: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008, 18: 1518-1529. 10.1101/gr.077479.108.PubMed CentralPubMedView ArticleGoogle Scholar
- Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K: DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res. 2008, 18: 1969-1978. 10.1101/gr.074070.107.PubMed CentralPubMedView ArticleGoogle Scholar
- Hattori N, Nishino K, Ko Y, Hattori N, Ohgane J, Tanaka S, Shiota K: Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 2004, 279: 17063-17069. 10.1074/jbc.M309002200.PubMedView ArticleGoogle Scholar
- Hattori N, Imao Y, Nishino K, Hattori N, Ohgane J, Yagi S, Tanaka S, Shiota K: Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells. 2007, 12: 387-396. 10.1111/j.1365-2443.2007.01058.x.PubMedView ArticleGoogle Scholar
- Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N: Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells. 2002, 7: 961-969. 10.1046/j.1365-2443.2002.00574.x.PubMedView ArticleGoogle Scholar
- Sato S, Yagi S, Arai Y, Hirabayashi K, Hattori N, Iwatani M, Okita K, Ohgane J, Tanaka S, Wakayama T, Yamanaka S, Shiota K: Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells. 2010, 15: 607-618. 10.1111/j.1365-2443.2010.01404.x.PubMedView ArticleGoogle Scholar
- Rodić N, Oka M, Hamazaki T, Murawski MR, Jorgensen M, Maatouk DM, Resnick JL, Li E, Terada N: DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells. 2005, 23: 1314-1323. 10.1634/stemcells.2005-0119.PubMedView ArticleGoogle Scholar
- Suzuki M, Sato S, Arai Y, Shinohara T, Tanaka S, Greally JM, Hattori N, Shiota K: A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse. Genes Cells. 2007, 12: 1305-1314. 10.1111/j.1365-2443.2007.01136.x.PubMedView ArticleGoogle Scholar
- Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, Liu XS: Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. USA. 2006, 103: 12457-12462. 10.1073/pnas.0601180103.PubMed CentralPubMedView ArticleGoogle Scholar
- Elstner M, Andreoli C, Ahting U, Tetko I, Klopstock T, Meitinger T, Prokisch H: MitoP2: an integrative tool for the analysis of the mitochondrial proteome. Mol. Biotechnol. 2008, 40: 306-315. 10.1007/s12033-008-9100-5.PubMedView ArticleGoogle Scholar
- Raijman L: Citrulline synthesis in rat tissues and liver content of carbamoyl phosphate and ornithine. Biochem. J. 1974, 138: 225-232.PubMed CentralPubMedView ArticleGoogle Scholar
- Cooper MP, Qu L, Rohas LM, Lin J, Yang W, Erdjument-Bromage H, Tempst P, Spiegelman BM: Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. Genes Dev. 2006, 20: 2996-3009. 10.1101/gad.1483906.PubMed CentralPubMedView ArticleGoogle Scholar
- Petruzzella V, Vergari R, Puzziferri I, Boffoli D, Lamantea E, Zeviani M, Papa S: A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. Hum. Mol. Genet. 2001, 10: 529-535. 10.1093/hmg/10.5.529.PubMedView ArticleGoogle Scholar
- Procaccio V, Wallace DC: Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations. Neurology. 2004, 62: 1899-1901.PubMed CentralPubMedView ArticleGoogle Scholar
- Yamashita Y, Kumabe T, Cho YY, Watanabe M, Kawagishi J, Yoshimoto T, Fujino T, Kang MJ, Yamamoto TT: Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Oncogene. 2000, 19: 5919-5925. 10.1038/sj.onc.1203981.PubMedView ArticleGoogle Scholar
- Zainelli GM, Dudek NL, Ross CA, Kim S, Muma NA: Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J. Neuropathol. Exp. Neurol. 2005, 64: 58-65.PubMedGoogle Scholar
- Imai S, Kikuchi R, Kusuhara H, Yagi S, Shiota K, Sugiyama Y: Analysis of DNA methylation and histone modification profiles of liver-specific transporters. Mol. Pharmacol. 2009, 75: 568-576. 10.1124/mol.108.052589.PubMedView ArticleGoogle Scholar
- Kikuchi R, Yagi S, Kusuhara H, Imai S, Sugiyama Y, Shiota K: Genome-wide analysis of epigenetic signatures for kidney-specific transporters. Kidney Int.Google Scholar
- Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M: Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 2004, 432: 1027-1032. 10.1038/nature03047.PubMedView ArticleGoogle Scholar
- Wolfrum C, Stoffel M: Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 2006, 3: 99-110. 10.1016/j.cmet.2006.01.001.PubMedView ArticleGoogle Scholar
- Wederell ED, Bilenky M, Cullum R, Thiessen N, Dagpinar M, Delaney A, Varhol R, Zhao Y, Zeng T, Bernier B, Ingham M, Hirst M, Robertson G, Marra MA, Jones S, Hoodless PA: Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res. 2008, 36: 4549-4564. 10.1093/nar/gkn382.PubMed CentralPubMedView ArticleGoogle Scholar
- Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, Kennedy BP, Wasserman WW: oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res. 2005, 33: 3154-3164. 10.1093/nar/gki624.PubMed CentralPubMedView ArticleGoogle Scholar
- Miura H, Tomaru Y, Nakanishi M, Kondo S, Hayashizaki Y, Suzuki M: Identification of DNA regions and a set of transcriptional regulatory factors involved in transcriptional regulation of several human liver-enriched transcription factor genes. Nucleic Acids Res. 2009, 37: 778-792. 10.1093/nar/gkn978.PubMed CentralPubMedView ArticleGoogle Scholar
- Ménard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabé-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD: An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron. 2002, 36: 597-610. 10.1016/S0896-6273(02)01026-7.PubMedView ArticleGoogle Scholar
- Wang J, Schreiber RD, Campbell IL: STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc. Natl. Acad. Sci. USA. 2002, 99: 16209-16214. 10.1073/pnas.252454799.PubMed CentralPubMedView ArticleGoogle Scholar
- Carmona MC, Iglesias R, Obregón M, Darlington GJ, Villarroya F, Giralt M: Mitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 2002, 277: 21489-21498. 10.1074/jbc.M201710200.PubMedView ArticleGoogle Scholar
- Jang J, Lee C: Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell. Immunol. 2003, 226: 11-19. 10.1016/j.cellimm.2003.11.004.PubMedView ArticleGoogle Scholar
- Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES, Mann M: Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell. 2003, 115: 629-640. 10.1016/S0092-8674(03)00926-7.PubMedView ArticleGoogle Scholar
- Hochreiter S, Clevert D, Obermayer K: A new summarization method for Affymetrix probe level data. Bioinformatics. 2006, 22: 943-949. 10.1093/bioinformatics/btl033.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.